Prebiotics and the health benefits of fiber: Current regulatory status, future research, and goals

Journal of Nutrition

Volumn 142, Issue 5, 2012, Pages 962-974

  Brownawell, Amy M ^a   Caers, Wim ^b   Gibson, Glenn R ^c   Kendall, Cyril W C ^d   Lewis, Kara D ^a   Ringel, Yehuda ^e   Slavin, Joanne L ^f  

^a Life Sciences Research Organization Inc   (United States)

^b Beneo Group   (Belgium)

^c UNIVERSITY OF READING   (United Kingdom)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; FRUCTOSE OLIGOSACCHARIDE; INULIN; MINERAL; PREBIOTIC AGENT; PROBIOTIC AGENT;

ARTICLE; BIFIDOBACTERIACEAE; BIOAVAILABILITY; CALCIUM ABSORPTION; CANADA; CARDIOVASCULAR DISEASE; CLOSTRIDIUM DIFFICILE INFECTION; CODEX ALIMENTARIUS; COLON CANCER; CROHN DISEASE; DIETARY FIBER; DIETARY INTAKE; ENTERITIS; EUROPE; FOOD SAFETY; FUNDING; GASTROINTESTINAL INFECTION; HEALTH PROMOTION; HUMAN; INFECTIOUS DIARRHEA; INFLAMMATION; INTESTINE FLORA; IRRITABLE COLON; JAPAN; KOREA; LACTOBACILLUS; MEDICAL RESEARCH; NUTRITIONAL HEALTH; NUTRITIONAL VALUE; OBESITY; RISK REDUCTION; SATIETY; SOUTH AFRICA; SOUTH AMERICA; SOUTHEAST ASIA; ULCERATIVE COLITIS; UNITED STATES; WEIGHT REDUCTION;

BACTERIA; COLONIC NEOPLASMS; DIARRHEA; DIETARY FIBER; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FUNCTIONAL FOOD; GASTROENTERITIS; GOALS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL DISEASES; INTESTINES; OBESITY; PREBIOTICS; PUBLIC HEALTH; RISK FACTORS; RISK REDUCTION BEHAVIOR; WORLD HEALTH;

EID: 84862093037     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.112.158147     Document Type: Article

References (135)

1. Slavin JL. Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc. 2008;108:1716-31.
2. Eshak ES, Iso H, Date C, Kikuchi S, Watanabe Y, Wada Y, Wakai K, Tamakoshi A. Dietary fiber intake is associated with reduced risk of mortality from cardiovascular disease among Japanese men and women. J Nutr. 2010;140:1445-53.
3. Mozaffarian D, Kumanyika SK, Lemaitre RN, Olson JL, Burke GL, Siscovick DS. Cereal, fruit, and vegetable fiber intake and the risk of cardiovascular disease in elderly individuals. JAMA. 2003;289:1659-66.
4. Pietinen P, Rimm EB, Korhonen P, Hartman AM, Willett WC, Albanes D, Virtamo J. Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Circulation. 1996;94:2720-7.
5. Rimm EB, Ascherio A, Giovannucci E, Spiegelman D, Stampfer MJ, Willett WC. Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA. 1996;275:447-51.
6. Wolk A, Manson JE, Stampfer MJ, Colditz GA, Hu FB, Speizer FE, Hennekens CH, Willett WC. Long-term intake of dietary fiber and decreased risk of coronary heart disease among women. JAMA. 1999;281:1998-2004.
7. Fraser GE, Sabate J, Beeson WL, Strahan TM. A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist Health Study. Arch Intern Med. 1992;152:1416-24.
8. Jacobs DR Jr, Meyer KA, Kushi LH, Folsom AR. Whole-grain intake may reduce the risk of ischemic heart disease death in postmenopausal women: the Iowa Women's Health Study. Am J Clin Nutr. 1998;68:248-57.
9. Morris JN, Marr JW, Clayton DG. Diet and heart: a postscript. BMJ. 1977;2:1307-14.
10. Bolton-Smith C, Woodward M, Tunstall-Pedoe H. The Scottish Heart Health Study. Dietary intake by food frequency questionnaire and odds ratios for coronary heart disease risk. II. The antioxidant vitamins and fibre. Eur J Clin Nutr. 1992;46:85-93.
11. Todd S, Woodward M, Tunstall-Pedoe H, Bolton-Smith C. Dietary antioxidant vitamins and fiber in the etiology of cardiovascular disease and all-causes mortality: results from the Scottish Heart Health Study. Am J Epidemiol. 1999;150:1073-80.
12. Bazzano LA, He J, Ogden LG, Loria CM, Whelton PK. Dietary fiber intake and reduced risk of coronary heart disease in US men and women: the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Intern Med. 2003;163:1897-904.
13. Jensen MK, Koh-Banerjee P, Hu FB, Franz M, Sampson L, Gronbaek M, Rimm EB. Intakes of whole grains, bran, and germ and the risk of coronary heart disease in men. Am J Clin Nutr. 2004;80:1492-9.
14. Pereira MA, O'Reilly E, Augustsson K, Fraser GE, Goldbourt U, Heitmann BL, Hallmans G, Knekt P, Liu S, Pietinen P, et al. Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med. 2004;164:370-6.
15. Khaw KT, Barrett-Connor E. Dietary fiber and reduced ischemic heart disease mortality rates in men and women: a 12-year prospective study. Am J Epidemiol. 1987;126:1093-102.
16. Liu S, Buring JE, Sesso HD, Rimm EB, Willett WC, Manson JE. A prospective study of dietary fiber intake and risk of cardiovascular disease among women. J Am Coll Cardiol. 2002;39:49-56.
17. Davis JN, Hodges VA, Gillham MB. Normal-weight adults consume more fiber and fruit than their age- and height-matched overweight/ obese counterparts. J Am Diet Assoc. 2006;106:833-40.
18. Howarth NC, Huang TT, Roberts SB, McCrory MA. Dietary fiber and fat are associated with excess weight in young and middle-aged US adults. J Am Diet Assoc. 2005;105:1365-72.
19. Liu S, Willett WC, Manson JE, Hu FB, Rosner B, Colditz G. Relation between changes in intakes of dietary fiber and grain products and changes in weight and development of obesity among middle-aged women. Am J Clin Nutr. 2003;78:920-7.
20. Maskarinec G, Takata Y, Pagano I, Carlin L, Goodman MT, Le Marchand L, Nomura AM, Wilkens LR, Kolonel LN. Trends and dietary determinants of overweight and obesity in a multiethnic population. Obesity (Silver Spring). 2006;14:717-26.
21. Tucker LA, Thomas KS. Increasing total fiber intake reduces risk of weight and fat gains in women. J Nutr. 2009;139:576-81.
22. Ludwig DS, Pereira MA, Kroenke CH, Hilner JE, Van Horn L, Slattery ML, Jacobs DR Jr. Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. JAMA. 1999;282:1539-46.
23. de Munter JS, Hu FB, Spiegelman D, Franz M, van Dam RM. Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review. PLoS Med. 2007;4:e261.
24. Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, Boeing H. Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. Arch Intern Med. 2007;167:956-65.
25. Giacco R, Parillo M, Rivellese AA, Lasorella G, Giacco A, D'Episcopo L, Riccardi G. Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type 1 diabetic patients. Diabetes Care. 2000;23:1461-6.
26. Kaline K, Bornstein SR, Bergmann A, Hauner H, Schwarz PE. The importance and effect of dietary fiber in diabetes prevention with particular consideration of whole grain products. Horm Metab Res. 2007;39:687-93.
27. Simpson HC, Simpson RW, Lousley S, Carter RD, Geekie M, Hockaday TD, Mann JI. A high carbohydrate leguminous fibre diet improves all aspects of diabetic control. Lancet. 1981;1:1-5.
28. Hopping BN, Erber E, Grandinetti A, Verheus M, Kolonel LN, Maskarinec G. Dietary fiber, magnesium, and glycemic load alter risk of type 2 diabetes in a multiethnic cohort in Hawaii. J Nutr. 2010;140:68-74.
29. Aldoori W, Ryan-Harshman M. Preventing diverticular disease. Review of recent evidence on high-fibre diets. Can Fam Physician. 2002;48:1632-7.
30. USDA. Carbohydrates. 2010 [cited 2010 Sep 22]. Available from: http://www.cnpp.usda.gov/Publications/DietaryGuidelines/2010/DGAC/Report/D-5-Carbohydrates.pdf.
31. Institute of Medicine. Dietary Reference Intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington, DC: National Academies Press; 2002.
32. Gibson GR, Scott KP, Rastall RA, Tuohy KM, Hotchkiss A, Dubert-Ferrandon A, Gareau M, Murphy EF, Saulnier D, Loh G, et al. Dietary prebiotics: current status and new definition. Food Science and Technology Bulletin: Functional Foods. 2010;7:1-19.
33. Cummings JH, Macfarlane GT. The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol. 1991;70:443-59.
34. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shapingmicrobial diversity in the human intestine. Cell. 2006;124:837-48.
35. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. Diversity of the human intestinal microbial flora. Science. 2005;308:1635-8.
36. Gordon JI, Ley RE, Wilson R, Mardis E, Xu J, Fraser CM, Relman DA. Extending our view of self: the Human Gut Microbiome Initiative (HGMI); 2011 [cited 2011 Feb 21]. Available from: http://www.genome.gov/Pages/Research/Sequencing/SeqProposals/HGMISeq.pdf.
37. Roberfroid MB. General introduction: prebiotics in nutrition. In: Gibson GR, Roberfroid MB, editors. Handbook of prebiotics. Boca Raton (FL): CRC Press; 2008. p. 1-11.
38. Ringel Y, Carroll IM. Alterations in the intestinal microbiota and functional bowel symptoms. Gastrointest Endosc Clin N Am. 2009;19:141-50.
39. Flint HJ, Duncan SH, Scott KP, Louis P. Interactions and competition within the microbial community of the human colon: links between diet and health. Environ Microbiol. 2007;9:1101-11.
40. Hague A, Singh B, Paraskeva C. Butyrate acts as a survival factor for colonic epithelial cells: further fuel for the in vivo versus in vitro debate. Gastroenterology. 1997;112:1036-40.
41. Barcenilla A, Pryde SE, Martin JC, Duncan SH, Stewart CS, Henderson C, Flint HJ. Phylogenetic relationships of butyrateproducing bacteria from the human gut. Appl Environ Microbiol. 2000;66:1654-61.
42. Juhlin-Dannfelt A. Ethanol effects of substrate utilization by the human brain. Scand J Clin Lab Invest. 1977;37:443-9.
43. Lindeneg O, Mellemgaard K, Fabricius J, Lundquist F. Myocardial utilization of acetate, lactate and free fatty acids after ingestion of ethanol. Clin Sci. 1964;27:427-35.
44. Lundquist F, Sestoft L, Damgaard SE, Clausen JP, Trap-Jensen J. Utilization of acetate in the human forearm during exercise after ethanol ingestion. J Clin Invest. 1973;52:3231-5.
45. Landau BR, Schumann WC, Chandramouli V, Magnusson I, Kumaran K, Wahren J. 14C-labeled propionate metabolism in vivo and estimates of hepatic gluconeogenesis relative to Krebs cycle flux. Am J Physiol. 1993;265:E636-47.
46. Salminen S, Bouley C, Boutron-Ruault MC, Cummings JH, Franck A, Gibson GR, Isolauri E, Moreau MC, Roberfroid M, Rowland I. Functional food science and gastrointestinal physiology and function. Br J Nutr. 1998;80 Suppl 1:S147-71.
47. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev. 2001;81:1031-64.
48. Smith EA, Macfarlane GT. Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J Appl Bacteriol. 1996;81:288-302.
49. Thornton JR. High colonic pH promotes colorectal cancer. Lancet. 1981;1:1081-3.
50. Kagnoff MF. Immunology of the digestive system. In: Johnson LR, editor. Physiology of the gastrointestinal tract. 2nd ed. New York: Raven Press; 1987. p. 1699-728.
51. Field CJ, McBurney MI, Massimino S, Hayek MG, Sunvold GD. The fermentable fiber content of the diet alters the function and composition of canine gut associated lymphoid tissue. Vet Immunol Immunopathol. 1999;72:325-41.
52. Pierre F, Perrin P, Champ M, Bornet F, Meflah K,Menanteau J. Shortchain fructo-oligosaccharides reduce the occurrence of colon tumors and develop gut-associated lymphoid tissue in Min mice. Cancer Res. 1997;57:225-8.
53. Gaskins HR, Mackie RI, May T, Garleb KA. Dietary fructooligosaccharide modulates large intestinal inflammatory responses to Clostridium difficile in antibiotic-compromised mice. Microb Ecol Health Dis. 1996;9:157-66.
54. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001;2:675-80.
55. Abreu MT. Immunologic regulation of toll-like receptors in gut epithelium. Curr Opin Gastroenterol. 2003;19:559-64.
56. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995;125:1401-12.
57. Gibson GR, Probert HM, Van Loo J, Rastall RA, Roberfroid MB. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev. 2004;17:259-75.
58. van Loo J, Coussement P, de Leenheer L, Hoebregs H, Smits G. On the presence of inulin and oligofructose as natural ingredients in the western diet. Crit Rev Food Sci Nutr. 1995;35:525-52.
59. Moshfegh AJ, Friday JE, Goldman JP, Ahuja JK. Presence of inulin and oligofructose in the diets of Americans. J Nutr. 1999;129: S1407-11.
60. Imperial-Sensus LLC. Generally recognized as safe (gras) notification for Frutafit. GRN 118 inulin. Sugarland, TX: Imperial-Sensus LLC;2002 Nov 14. Report No.: GRN No. 118.
61. GTC Nutrition Company. Generally recognized as safe notification for short-chain fructooligosaccharide. GRN 44. Golden (CO): GTC Nutrition Company; 2000 Apr 17. Report No.: GRN No. 44.
62. GTC Nutrition Company. Generally recognized as safe notification for galacto-oligosaccharide. GRN 285. Golden (CO): GTC Nutrition Company; 2009 Mar 12. Report No.: GRAS GRN 285.
63. Coussement PA. Inulin and oligofructose: safe intakes and legal status. J Nutr. 1999;129:S1412-7.
64. Speigel JE. Safety and benefits of fructooligosaccharides as food ingredients. Food Technol. 1994;48:85-9.
65. Briet F, Achour L, Flourie B, Beaugerie L, Pellier P, Franchisseur C, Bornet F, Rambaud JC. Symptomatic response to varying levels of fructo-oligosaccharides consumed occasionally or regularly. Eur J Clin Nutr. 1995;49:501-7.
66. Livesey G. Tolerance of low-digestible carbohydrates: a general view. Br J Nutr. 2001;85 Suppl 1:S7-16.
67. Rogosa M. Genus III. Bifidobacterium Orla-Fensen 1924, 472. In: Buchanan RE, Gibbons NE, editors. Bergey's manual of determinative bacteriology. 8th ed. Baltimore (MD): Waverly Press; 1974. p. 669-74.
68. Livesey G. The energy values of dietary fibre and sugar alcohols for man. Nutr Res Rev. 1992;5:61-84.
69. Roberfroid M, Gibson GR, Delzenne N. The biochemistry of oligofructose, a nondigestible fiber: an approach to calculate its caloric value. Nutr Rev. 1993;51:137-46.
70. Roberfroid MB. Caloric value of inulin and oligofructose. J Nutr. 1999;129:S1436-7.
71. FUFOSE. Scientific concepts of functional foods in Europe. Consensus document. Br J Nutr. 1999;81 Suppl 1:S1-27.
72. Cummings JH, Christie S, Cole TJ. A study of fructo oligosaccharides in the prevention of travellers' diarrhoea. Aliment Pharmacol Ther. 2001;15:1139-45.
73. Drakoularakou A, Tzortzis G, Rastall RA, Gibson GR. A doubleblind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers' diarrhoea. Eur J Clin Nutr. 2010;64:146-52.
74. Lewis S, Burmeister S, Brazier J. Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study. Clin Gastroenterol Hepatol. 2005;3:442-8.
75. Welters CF, Heineman E, Thunnissen FB, van den Bogaard AE, Soeters PB, Baeten CG. Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis. Dis Colon Rectum. 2002;45:621-7.
76. Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh SV, O'Neil DA, Macfarlane GT. Synbiotic therapy (Bifidobacterium longum/ Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut. 2005;54:242-9.
77. Benjamin JL, Hedin CR, Koutsoumpas A, Ng SC, McCarthy NE, Hart AL, Kamm MA, Sanderson JD, Knight SC, Forbes A, et al. Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease. Gut. 2011;60:923-9.
78. Casellas F, Borruel N, Torrejon A, Varela E, Antolin M, Guarner F, Malagelada JR. Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin. Aliment Pharmacol Ther. 2007;25:1061-7.
79. Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther. 2009;29:508-18.
80. Boutron-Ruault MC, Marteau P, Lavergne-Slove A, Myara A, Gerhardt MF, Franchisseur C, Bornet F. Effects of a 3-mo consumption of short-chain fructo-oligosaccharides on parameters of colorectal carcinogenesis in patients with or without small or large colorectal adenomas. Nutr Cancer. 2005;53:160-8.
81. Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson PC, Klinder A, O'Riordan M, O'Sullivan GC, Pool-Zobel B, et al. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr. 2007;85:488-96.
82. Limburg PJ, Mahoney MR, Ziegler KL, Sontag SJ, Schoen RE, Benya R, Lawson MJ, Weinberg DS, Stoffel E, Chiorean M, et al. Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention. Cancer Prev Res (Phila). 2011;4:259-69.
83. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Stampfer MJ, Rosner B, Speizer FE, Willett WC. Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med. 1999;340:169-76.
84. Coudray C, Fairweather-Tait SJ. Do oligosaccharides affect the intestinal absorption of calcium in humans? Am J Clin Nutr. 1998;68:921-3.
85. van den Heuvel EG, Schoterman MH, Muijs T. Transgalactooligosaccharides stimulate calcium absorption in postmenopausal women. J Nutr. 2000;130:2938-42.
86. Tahiri M, Tressol JC, Arnaud J, Bornet FR, Bouteloup-Demange C, Feillet-Coudray C, Brandolini M, Ducros V, Pepin D, Brouns F, et al. Effect of short-chain fructooligosaccharides on intestinal calcium absorption and calcium status in postmenopausal women: a stableisotope study. Am J Clin Nutr. 2003;77:449-57.
87. Demigné C, Jacobs H, Moundras C, Davicco MJ, Horcajada MN, Bernalier A, Coxam V. Comparison of native or reformulated chicory fructans, or non-purified chicory, on rat cecal fermentation and mineral metabolism. Eur J Nutr. 2008;47:366-74.
88. Abrams SA, Griffin IJ, Hawthorne KM, Liang L, Gunn SK, Darlington G, Ellis KJ. A combination of prebiotic short- and long-chain inulintype fructans enhances calcium absorption and bone mineralization in young adolescents. Am J Clin Nutr. 2005;82:471-6.
89. Abrams SA, Griffin IJ, Hawthorne KM, Ellis KJ. Effect of prebiotic supplementation and calcium intake on body mass index. J Pediatr. 2007;151:293-8.
90. Jenkins DJ, Kendall CW, Popovich DG, Vidgen E, Mehling CC, Vuksan V, Ransom TP, Rao AV, Rosenberg-Zand R, Tariq N, et al. Effect of a very-high-fiber vegetable, fruit, and nut diet on serum lipids and colonic function. Metabolism. 2001;50:494-503.
91. Jenkins DJ, Kendall CW, Faulkner D, Vidgen E, Trautwein EA, Parker TL, Marchie A, Koumbridis G, Lapsley KG, Josse RG, et al. A dietary portfolio approach to cholesterol reduction: combined effects of plant sterols, vegetable proteins, and viscous fibers in hypercholesterolemia. Metabolism. 2002;51:1596-604.
92. Jenkins DJ, Kendall CW, Marchie A, Faulkner DA, Wong JM, de Souza R, Emam A, Parker TL, Vidgen E, Lapsley KG, et al. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA. 2003;290:502-10.
93. Davidson MH, Maki KC. Effects of dietary inulin on serum lipids. J Nutr. 1999;129:S1474-7.
94. Forcheron F, Beylot M. Long-term administration of inulin-type fructans has no significant lipid-lowering effect in normolipidemic humans. Metabolism. 2007;56:1093-8.
95. Wong JM, Kendall CW, de Souza R, Emam A, Marchie A, Vidgen E, Holmes C, Jenkins DJ. The effect on the blood lipid profile of soy foods combined with a prebiotic: a randomized controlled trial. Metabolism. 2010;59:1331-40.
96. Nadal I, Santacruz A, Marcos A, Warnberg J, Garagorri M, Moreno LA, Martin-Matillas M, Campoy C, Marti A, Moleres A, et al. Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents. Int J Obes (Lond). 2009;33:758-67.
97. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457:480-4.
98. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444:1022-3.
99. Armougom F, Henry M, Vialettes B, Raccah D, Raoult D. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS ONE. 2009;4:e7125.
100. Schwiertz A, Taras D, Schafer K, Beijer S, Bos NA, Donus C, Hardt PD. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring). 2010;18:190-5.
101. Duncan SH, Lobley GE, Holtrop G, Ince J, Johnstone AM, Louis P, Flint HJ. Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes (Lond). 2008;32:1720-4.
102. Santacruz A, Marcos A, Warnberg J, Marti A, Martin-Matillas M, Campoy C, Moreno LA, Veiga O, Redondo-Figuero C, Garagorri JM, et al. Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity (Silver Spring). 2009;17:1906-15.
103. Santacruz A, Collado MC, Garcia-Valdes L, Segura MT, Martin-Lagos JA, Anjos T, Marti-Romero M, Lopez RM, Florido J, Campoy C, et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr. 2010;104:83-92.
104. Peters HP, Boers HM, Haddeman E, Melnikov SM, Qvyjt F. No effect of added b-glucan or of fructooligosaccharide on appetite or energy intake. Am J Clin Nutr. 2009;89:58-63.
105. Archer BJ, Johnson SK, Devereux HM, Baxter AL. Effect of fat replacement by inulin or lupin-kernel fibre on sausage patty acceptability, post-meal perceptions of satiety and food intake in men. Br J Nutr. 2004;91:591-9.
106. Parnell JA, Reimer RA. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr. 2009;89:1751-9.
107. Cani PD, Lecourt E, Dewulf EM, Sohet FM, Pachikian BD, Naslain D, De Backer F, Neyrinck AM, Delzenne NM. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr. 2009;90:1236-43.
108. Cani PD, Joly E, Horsmans Y, Delzenne NM. Oligofructose promotes satiety in healthy human: a pilot study. Eur J Clin Nutr. 2006;60:567-72.
109. Hess JR, Birkett AM, Thomas W, Slavin JL. Effects of short-chain fructooligosaccharides on satiety responses in healthy men and women. Appetite. 2011;56:128-34.
110. Health Canada. Guidance document :the use of probiotic microorganisms in food. Ottawa: Health Canada; 2009.
111. AFSSA. French approval for inulin as prebiotic; 2004 [cited 2011 Mar 9]. Available from: http://www.afssa.fr/Documents/NUT2004- sa0365.pdf.
112. AFSSA. AFSSA report of the effects of probiotics and prebiotics on flora and immunity. AFFSA; 2005 [cited 2011 Mar 9]. Available from: http://www.isapp.net/docs/AFFSAprobioticprebioticfloraimmunity05. pdf.
113. Netherlands Nutrition Centre. Assessment report of Netherlands Nutrition Centre on inulin in Vitaalbrood. Netherlands Nutrition Centre; 2008 [cited 2011 Mar 9]. Available from: http://www.voedingscentrum.nl/ resources2008/beoordelingsrapport_vitaalbrood_florapdf.pdf.
114. Bimuno. Improve digestive health with Bimuno; 2010 [cited 2010 Oct 12]. Available from: http://www.bimuno.com/.
115. EUROPA. European Union Register of nutrition and health claims made on food: rejected health claims; 2010 [cited 2010 Sep 23]. Available from: http://ec.europa.eu/food/food/labellingnutrition/claims/community_register/rejected_health_claims_en.htm.
116. Depeint F, Tzortzis G, Vulevic J, I'anson K, Gibson GR. Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebocontrolled intervention study. Am J Clin Nutr. 2008;87:785-91.
117. Vulevic J, Drakoularakou A, Yaqoob P, Tzortzis G, Gibson GR. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr. 2008;88:1438-46.
118. EFSA Panel on Dietetic Products Nutrition and Allergies. Guidance on the scientific requirements for health claims related to gut and immune function. EFSA J. 2011;9:1984.
119. Japanese Ministry of Health Labour and Welfare. Food for Specified Health Uses (FOSHU). Japanese Ministry of Health, Labour, and Welfare; 2010 [cited 2010 Oct 12]. Available from: http://www. mhlw.go.jp/english/topics/foodsafety/fhc/02.html.
120. Korea FDA. Health functional food code. Chungcheongbuk-do, Korea: Korea Food and Drug Administration; 2010.
121. Agri-Food and Veterinary Authority of Singapore. Food labelling and advertisements. Agri-Food and Veterinary Authority of Singapore;2011 [cited 2011 Mar 8]. Available from: http://www.ava.gov.sg/ FoodSector/FoodLabelingAdvertisement/.
122. Tee E-S, Sulong F. Make effective use of nutrition information on food labels. Ministry of Health Malaysia; 2010 [cited 2011 Mar 8]. Available from: http://www.nutrition.moh.gov.my/pdf/mdg2010/Key%20Message%2014.pdf.
123. Nik Daud NI. Malaysian legal requirements for innovative foods. World of Food Science; 2011 [cited 2011 Mar 9]. Available from: http://www.worldfoodscience.org/cms/?pid=1004358.
124. Food Safety and Quality Division. Guide to nutrition labelling and claims. Malaysia: Ministry of Health Malaysia; 2010.
125. Food and Drug Administration Thailand. Prebiotics [in Thai]. Medical and health product bulletin; 2011 [cited 2011 Mar 8]. 5:1-31. Available from: http://www.fda.moph.go.th/fda-net/html/ product/apr/about/bulletin%205-4.pdf.
126. Southeast Asia Region ILSI. Seminar and Workshop on Nutrition Labeling, Claims and Communication Strategies for the Consumer, Sept 20-21; 2010, Kuala Lumpur, Malaysia, Meeting Summary. ILSI Southeast Asia Region 2010 [cited 2011 Mar 9]. Available from: http://www.ilsi.org/SEA_Region/Documents/Nutrition%20Labeling%20Claim%20Meeting%20Summary%20Sept2010.pdf.
127. Agencia Nacional de Vigláncia Sanitá ria. Alimentos com Alegaçõ es de Propriedades Funcionais e ou de Saú de, Novos Alimentos/ Ingredientes, Substâncias Bioativas e Probió ticos. ANVISA; 2011 [cited 2011 Mar 11]. Available from: http://www.anvisa.gov.br/ alimentos/comissoes/tecno_lista_alega.htm.
128. de Chile Ministerio de Salud R. Normas Técnicas Sobre Directrices Nutricionales Que Indica, Para La Declaración De Propiedades Saludables De Los Alimentos. Resolucion Exenta No. DE 2005. Republica de Chile; 2005 [cited 2011 Mar 11]. Available from: http://juridico1.minsal.cl/resolucion_556_2005.doc.
129. Ministerio de la Protección Social Columbia South America. Resolucion 288 De 2008 (enero 31). Diario Oficial No. 46.894 de 6 de febrero de 2008. Por la cual se establece el reglamento técnico sobre requisitos de rotulado o etiquetado nutricional que deben cumplir los alimentos envasados para consumo humano. FAO; 2008 [cited 2011 Mar 11]. Available from: http://faolex.fao.org/docs/texts/col78822.doc.
130. South African Health Products Regulatory Authority. Foodstuffs, cosmetics and disinfectants Act, 1972 (ACT 54 of 1972). Regulations relating to the labelling and advertising of food stuffs. Department of Health South Africa; 2011 [cited 2011 Mar 11]. Available from: http:// www.hahnlaw.co.za/Food%20Labelling%20Regs%20R%20146%20of%201March%202010.pdf.
131. ILSI North America, ILSI Europe. 9th Vahouny Fibre Symposium: Session 10: implementation Issues of the Codex definition of dietary fibre. Part 2. Building scientific agreement on resolution of the issues Workshop format facilitated by Julie Miller-Jones and Martine Champ (Session sponsored by ILSI North America and ILSI Europe); Washington, DC: ILSI North America; 2010.
132. Howlett JF, Betteridge VA, Champ M, Craig SA, Meheust A, Jones JM. The definition of dietary fiber: discussions at the Ninth Vahouny Fiber Symposium: building scientific agreement. Food Nutr Res. 2010;54:5750.
133. Pineiro M, Asp NG, Reid G, Macfarlane S, Morelli L, Brunser O, Tuohy K. FAO Technical meeting on prebiotics. J Clin Gastroenterol. 2008;42 Suppl 3:S156-9.
134. GeierMS, Butler RN, Giffard PM, Howarth GS. Prebiotic and synbiotic fructooligosaccharide administration fails to reduce the severity of experimental colitis in rats. Dis Colon Rectum. 2007;50:1061-9.
135. Life Sciences Research Organization. Workshop on Prebiotics and the Health Benefits of Fiber: future research and goals. Life Sciences Research Organization; 2011 [cited 2011 Feb 18]. Available from: http://www.lsro.org/prebiotics/prebiotics_summary4wkshp.html.